Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studiesYoshiaki Nakamura, Takayuki Yoshino, Yoshito Komatsu et al.|Nature Medicine|2020Cited by 366
Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigmYoshiaki Nakamura, Kohei Shitara, Akihito Kawazoe et al.|Nature Reviews Clinical Oncology|2021Cited by 301
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trialYoshiaki Nakamura, Takayuki Yoshino|Nature Medicine|2021Cited by 241
Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping PanelJason Willis, Justin I. Odegaard, Martina I. Lefterova et al.|Clinical Cancer Research|2019Cited by 237
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Tanios Bekaii‐Saab, Nobumasa Mizuno et al.|Journal of Clinical Oncology|2023Cited by 100